Susquehanna International Group, LLP Cassava Sciences Inc Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

A detailed history of Susquehanna International Group, LLP transactions in Cassava Sciences Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 690,924 shares of SAVA stock, worth $19.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

690,924

Previous 15,688 4304.16%

Holding current value

$19.4 Million

Previous $318,000 2583.02%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$12.35 - $26.11 $8.34 Million - $17.6 Million	675,236 Added 4304.16%	690,924 $8.53 Million
Q1 2024 May 07, 2024	SELL	$18.44 - $26.41 $26,885 - $38,505	-1,458 Reduced 8.5%	15,688 $318,000
Q4 2023 Feb 14, 2024	SELL	$12.64 - $30.11 $65,879 - $156,933	-5,212 Reduced 23.31%	17,146 $385,000
Q3 2023 Nov 14, 2023	SELL	$16.64 - $25.32 $2.64 Million - $4.02 Million	-158,921 Reduced 87.67%	22,358 $372,000
Q2 2023 Aug 11, 2023	SELL	$21.59 - $27.88 $1.3 Million - $1.68 Million	-60,411 Reduced 25.0%	181,279 $4.44 Million
Q1 2023 May 16, 2023	BUY	$23.46 - $36.44 $3.8 Million - $5.9 Million	161,810 Added 202.57%	241,690 $5.83 Million
Q4 2022 Feb 14, 2023	BUY	$27.82 - $44.16 $1.44 Million - $2.29 Million	51,887 Added 185.36%	79,880 $2.36 Million
Q3 2022 Nov 14, 2022	SELL	$16.33 - $51.06 $458,432 - $1.43 Million	-28,073 Reduced 50.07%	27,993 $1.17 Million
Q2 2022 Aug 15, 2022	SELL	$17.22 - $38.47 $3.05 Million - $6.8 Million	-176,845 Reduced 75.93%	56,066 $1.58 Million
Q1 2022 May 16, 2022	SELL	$32.6 - $53.05 $874,560 - $1.42 Million	-26,827 Reduced 10.33%	232,911 $8.65 Million
Q4 2021 Feb 14, 2022	SELL	$36.77 - $90.91 $4.25 Million - $10.5 Million	-115,483 Reduced 30.78%	259,738 $11.4 Million
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $991,885 - $3.21 Million	23,735 Added 6.75%	375,221 $23.3 Million
Q2 2021 Aug 11, 2021	SELL	$32.15 - $89.72 $525,363 - $1.47 Million	-16,341 Reduced 4.44%	351,486 $30 Million
Q1 2021 May 17, 2021	BUY	$7.09 - $87.95 $86,086 - $1.07 Million	12,142 Added 3.41%	367,827 $16.5 Million
Q4 2020 Feb 16, 2021	BUY	$6.79 - $12.25 $1.6 Million - $2.88 Million	235,351 Added 195.58%	355,685 $2.43 Million
Q3 2020 Nov 16, 2020	BUY	$2.86 - $11.51 $46,206 - $185,955	16,156 Added 15.51%	120,334 $1.39 Million
Q2 2020 Aug 14, 2020	SELL	$2.04 - $9.64 $192,712 - $910,661	-94,467 Reduced 47.56%	104,178 $321,000
Q1 2020 May 15, 2020	BUY	$3.26 - $9.65 $647,582 - $1.92 Million	198,645 New	198,645 $816,000
Q4 2019 Feb 14, 2020	SELL	$1.1 - $6.12 $13,417 - $74,651	-12,198 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.04 - $1.45 $10,730 - $14,961	-10,318 Reduced 45.83%	12,198 $15,000
Q2 2019 Aug 16, 2019	BUY	$1.02 - $1.34 $441 - $580	433 Added 1.96%	22,516 $28,000
Q2 2019 Aug 14, 2019	SELL	$1.02 - $1.34 $43,178 - $56,724	-42,332 Reduced 65.72%	22,083 $27,000
Q1 2019 May 15, 2019	BUY	$0.92 - $1.29 $59,261 - $83,095	64,415 New	64,415 $83,000

Others Institutions Holding SAVA

# of Institutions

184

Shares Held

13.3M

Call Options Held

1.38M

Put Options Held

2.04M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $1.13B
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Cassava Sciences Inc Transaction History